Trial
NCT02189213
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
Columbia University
Condition
Generalized Anxiety Disorder
Intervention
Sertraline
Why stopped
Insufficient funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-11